Candel Therapeutics Inc Financial Flexibility Index
Candel Therapeutics Inc financial flexibility index. Candel Therapeutics Inc (CADL) has a Financial Flexibility Index of -0.27x as of March 2026. Free cash flow of $-17.36 Million (operating CF $-18.04 Million minus capex $675.00K) represents 0% of total liabilities ($63.89 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Candel Therapeutics Inc (2019–2025)
Financial flexibility index of Candel Therapeutics Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Candel Therapeutics Inc across 7 annual periods. Check CADL operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Candel Therapeutics Inc Financial Flexibility Index by Year (2019–2025)
Candel Therapeutics Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Candel Therapeutics Inc. For the full cash flow conversion analysis, see Candel Therapeutics Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.51x | $-37.72 Million | $-38.31 Million | $73.27 Million | ▲ +22.7% |
| 2024 | -0.67x | $-27.01 Million | $-27.02 Million | $40.54 Million | ▲ +43.9% |
| 2023 | -1.19x | $-33.79 Million | $-34.24 Million | $28.46 Million | ▼ -21.4% |
| 2022 | -0.98x | $-30.12 Million | $-31.42 Million | $30.80 Million | ▼ -20.3% |
| 2021 | -0.81x | $-20.38 Million | $-22.22 Million | $25.07 Million | ▼ -562.1% |
| 2020 | -0.12x | $-7.59 Million | $-9.07 Million | $61.84 Million | ▼ -32.0% |
| 2019 | -0.09x | $-5.02 Million | $-5.18 Million | $53.94 Million | — |